If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
312.00    0.00 (0.00%)
Bid:
310.00
Ask:
314.00
Spread: 4.00 (1.29%)
Market Cap: £39.59m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

20 Jan 2026 07:00

RNS Number : 5104P
System1 Group PLC
20 January 2026
 

 

 

 

 

20 January 2026

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

Trading Update - Growth in Platform Revenue in Q3 over first two quarters-

FY26 guidance maintained

 

System1 www.system1group.com today issues an update on trading for the quarter ended 31 December 2025 ("Q3 FY26", "Q3").

 

Platform revenue in Q3 was higher than the preceding two quarters, benefiting from increased Adtesting revenue in the UK and Europe which in H1 experienced reduced, but ongoing, spend by many clients due to the wider macroeconomic uncertainty.

 

Platform revenue was in line with the previous record Q3 FY25, and grew by 1% against that Q3 FY25 in constant currency. US platform revenue was in line with H1, and momentum in Innovation Platform revenue continued.

 

Non-platform revenue was £0.4m lower than in Q3 FY25 resulting in a 4% fall in reported total Group revenue (3% at constant currency) compared with last year's record Q3.

 

Revenue from new client wins grew by 10% in the first nine months of FY26 compared with the same period in FY25. These new clients contributed £7.4m of the £25.7m Platform Revenue in the year to date, a third of it in the US, and provide significant opportunities for future growth.

 

The Group held net cash of £8.3m at the end of December (Dec 2024: £10.2m) following the £1.4m dividend payment in October.

 

The Board maintains the FY26 guidance1 it provided on 23 September 2025 and in the interim results on 2 December 2025.

 

 

 

 

Revenue £ million - unaudited

Q3

Q3

Q3

YTD

YTD

YTD

FY26

FY25

% YoY

FY26

FY25

% YoY

Predict Your (data)

8.1

8.2

-1%

21.5

21.5

0%

Improve Your (data-led consultancy)

1.4

1.3

8%

4.2

4.7

-11%

Platform Revenue

9.5

9.5

0%

25.7

26.2

-2%

Other consultancy (non-platform)

0.3

0.7

-57%

1.2

2.3

-48%

Total Revenue

9.8

10.2

-4%

26.9

28.5

-6%

 

Commenting on the trading update, CEO James Gregory said: "Q3 saw a recovery in our revenue, particularly in UK & Europe, with many of our largest clients' Adtesting spend normalising after a reduced H1, providing some momentum for Q4. We therefore remain confident in maintaining our guidance for the year."

 

Further information on the Company can be found at www.system1group.com.

 

1 For the purpose of this announcement, the guidance provided in the 23 September 2025 announcement was for FY26 Revenue to be broadly in line with the £37m achieved in FY25, and Adjusted Profit beforeTaxation2 in a range between £2.0 to £2.5 million.

2 Adjusted Profit is Profit before Taxation excluding share-based payments

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)7467 990147

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

 

Canaccord Genuity Limited (Nominated Adviser & Broker)

 

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts / Harry Rees

 

Singer Capital Markets (Joint Broker)

Tel: +44 (0) 20 7496 3000 

James Moat / James Fischer / Sara Hale

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKSRRNKUAAUR
Date   Source Headline
14th Oct 20197:00 amRNSTrading Update
5th Sep 20197:00 amRNSGrant of Options
1st Aug 20197:00 amRNSResult of AGM
28th Jun 201912:30 pmRNSAnnual Report and Notice of AGM
12th Jun 20197:00 amRNSHolding(s) in Company
6th Jun 20197:00 amRNSDividend Declaration
6th Jun 20197:00 amRNSFinancial results to 31 March 2019
18th Apr 20197:00 amRNSGrant of Options
15th Apr 20197:00 amRNSTrading Update
19th Nov 20187:00 amRNSDirector/PDMR Shareholding
6th Nov 20188:24 amRNSHolding(s) in Company
6th Nov 20187:00 amRNSPDMR Shareholding
2nd Nov 20184:08 pmRNSDividend Declaration
2nd Nov 20187:00 amRNSInterim Results
15th Oct 20187:00 amRNSTrading Update
2nd Oct 20189:09 amRNSHolding(s) in Company
28th Sep 201810:15 amRNSHolding(s) in Company
21st Sep 201811:56 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSAd Ratings and Trading Update
31st Aug 20185:02 pmRNSTotal Voting Rights
20th Aug 20187:00 amRNSHolding(s) in Company
17th Aug 20182:58 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSExercise of Options
26th Jul 20187:00 amRNSDirectorate Change
25th Jul 201812:04 pmRNSResult of AGM
24th Jul 20187:00 amRNSBoard Changes
10th Jul 20189:12 amRNSHolding(s) in Company
9th Jul 201811:31 amRNSHolding(s) in Company
2nd Jul 20183:50 pmRNSAnnual Report and Notice of AGM
28th Jun 20185:57 pmRNSHolding(s) in Company
12th Jun 20187:00 amRNSExercise of Options
11th Jun 20187:00 amRNSBoard Change
5th Jun 20184:31 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSDirector/PDMR Shareholding
4th Jun 20183:10 pmRNSDividend Declaration
1st Jun 20187:00 amRNSFinancial results to 31 March 2018
23rd May 20188:26 amRNSHolding(s) in Company
27th Apr 20184:30 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSTrading Update
9th Mar 20183:30 pmRNSTransaction in Own Shares
9th Mar 20187:00 amRNSExercise of Options and Buyback of Option Shares
8th Jan 20187:00 amRNSTrading Update
28th Nov 201711:52 amRNSHolding(s) in Company
27th Nov 20179:48 amRNSHolding(s) in Company
17th Nov 20177:00 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSInterim Results
16th Oct 20177:00 amRNSTrading Update
2nd Oct 20174:26 pmRNSHolding(s) in Company
12th Sep 20172:31 pmRNSHolding(s) in Company
21st Aug 20175:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.